New England Biolabs, Inc. opens eighth subsidiary in Australia

Ipswich, MA (July 1, 2019) – New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. Australia’s Life Sciences industry is home to more than 230,000 life science researchers, working towards advancing discoveries... Read more

IDT and 3CR pool expertise to provide a custom genotyping solution for low- to high-throughput screening

Jul 2, 2019 New high-performance, cost-effective PACE SNP assays will lower the cost and improve the reliability of SNP or indel screening CORALVILLE, IA (July 2, 2019) – In the latest collaboration in a series to advocate for genomics research, Integrated DNA Technologies (IDT) is teaming up with 3CR Bioscience (3CR) to widen access to quality custom solutions for genotyping screening.... Read more

Thermo Fisher Scientific Completes Sale of Anatomical Pathology Business to PHC Holdings Corporation

WALTHAM, Mass., June 28, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed the previously announced sale of its Anatomical Pathology business to PHC Holdings Corporation, a leading global healthcare company providing innovative solutions, for approximately $1.14 billion in cash. The Anatomical Pathology... Read more

Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents. The first complaint was filed against Complete Genomics, Inc. and other BGI entities in the United States District Court for the Northern District of California... Read more

IDT signs strategic partnership with Chinese medical sequencing firm ChosenMed

Jun 27, 2019 Partnership strengthens IDT’s position as an NGS leader in China CORALVILLE, IA (June 27, 2019) – Integrated DNA Technologies (IDT) announces that is has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing firm focused on personalized medicine and transformation healthcare in China. As part of the collaboration, IDT... Read more

Danaher Announces New Dental Company To Be Named Envista Holdings Corporation

WASHINGTON, June 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Envista Holdings Corporation (“Envista” or the “Company”) will be the name of the separate company Danaher intends to create and take public via an initial public offering in the second half of 2019.  Envista will be comprised of three operating companies within... Read more

Promega 2019 Corporate Responsibility Report Highlights Commitments to Environmental Sustainability, Employee Well-Being and Community Support

Madison, WI USA. (June 26, 2019) Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices and resulting trends through the previous year. The 2019 report documents how, over the last three years, an overall culture of sustainability resulted in an 8% reduction in the company’s carbon-to-revenue footprint. “We not... Read more

Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration

Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration Studies aim to elucidate infertility genetics for development of noninvasive test to support decision making and improved outcomes for women pursuing fertility treatment CARLSBAD, Calif., June 19, 2019 /PRNewswire/ — Thermo Fisher Scientific announced today that it has entered into a global research collaboration... Read more

X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration

June 19, 2019 First plan apochromat objectives in the world to achieve a numerical aperture of 1.5*1 were launched concurrently It is difficult to improve one area of an objective lens, such as numerical aperture, without tradeoffs in another area, like chromatic aberration correction. However, X Line objectives overcome the common tradeoffs by simultaneously improving optical... Read more